Patent · US Active

Immunogenic composition for use in vaccination against staphylococci

US10548963B2 · kind B2 · utility

2Cited by

6References

9Claims

0Family size

Assignee

GLAXOSMITHKLINE BIOLOGICALS SA · BE

Inventors

Cindy Castado · Rixensart, BE
Nicolas Pierre Fernand Lecrenier · Rixensart, BE
Cecile Anne Neyt · Rixensart, BE
Jan Poolman · Broek in Waterland, NL

Key dates

Filing date	Jul 26, 2018
Grant date	Feb 4, 2020
Priority date	—
Expiry date	Jul 26, 2038

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present application relates to immunogenic compositions comprising a mixture of staphylococcal antigens which combines antigen having different functions, for instance, combinations including a staphylococcal extracellular component binding protein and a staphylococcal transporter protein or a staphylococcal extracellular component binding protein and a staphylococcal regulator of virulence or toxin or a staphylococcal transporter protein and a staphylococcal regulator of virulence or toxin. Vaccines, methods of treatment, uses of and processes to make a staphylococcal vaccine are also described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.